跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/CTRI/2023/02/049829
CTRI/2023/02/049829已完成不适用

To evaluate the in-vivo efficacy and safety of a skin care regime in terms of skin brightening & skin radiance on healthy female subjects.

BRIGHT LIFECARE PVT. LTD.1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2023年2月20日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
36
试验地点
1
主要终点
To evaluate the in-vivo efficacy and safety of a skin care regime in terms of skin brightening & skin radiance on healthy female subjects.
研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

OBJECTIVE

To evaluate the in-vivo efficacy and safety of a skin care regime in terms of skin brightening & skin radiance on healthy female subjects.

Duration of study: 28 days study

Kinetics: T0, T+14 days & T+28 days

Population: 36 Female volunteers

The evaluation is performed using:

  • Subject Self Evaluation

  • Dermatological Evaluation: Cosmetic Acceptability

  • Chromametry

  • CLBT (Color, Luminosity, Brightness, Transparency)

Product application : Application of test  regime containing 3 test products is twice a day at morning & evening on whole face for the period of 28 days.

Modalities of application for Product A:

Wet your face with water. Take 0.5 gm quantity of test product on palm and massage all over the face avoiding eye area. Rinse thoroughly with water and pat dry.

Modalities of application for Product B:

After application of product A take 4-5 drops of test product on palm and apply on whole face. Gently spread the test product in outward direction. Ensure that you don’t rub the product into your skin.

Modalities of application for Product C:

After application of product A & B take approx. 0.5 gm quantity of test product and apply dot wise on the whole face. Gently spread the test product using only fingers in outward direction. Ensure that you don’t rub the product into your skin.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 35.00 Year(s)（—）
性别
Female

入选标准

  • •The study will be conducted on subjects who will fulfill the following criteria: 1.Indian / Asian female subjects 2.Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup) 3.Between 18 to 35 years and above.
  • •4.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….) 5.Having dull skin.
  • •6.Having wheatish to dark complexion.

排除标准

  • •1.Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2.Having refused to give her assent by signing the consent form 3.Taking part in another study liable to interfere with this study 4.Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area 5.Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months) 6.Having a progressive asthma (either under treatment or last fit in the last 2 years) 7.Being epileptic 8.Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 9.Having cutaneous hypersensitivity 10.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex
  • •Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 12.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. 13.Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit 14.Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted). 15.Refusing to follow the restrictions below during the study:.
  • •Do not take part in any family planning activities leading to pregnancy and breastfeeding.
  • •Do not take part in another study liable to interfere with this study.
  • •Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
  • •Do not change her cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit.
  • •During the study: Do not use other cosmetic products than the tested products to the studied areas (only usual cleanser/soap is accepted).
  • •The day of the measurements: No test product must be used (only face cleaned with water is accepted) 16.Having started, changed or stopped a hormonal treatment (hormonal contraception, Hormone Replacement Therapy) in the past 3 months. 17.Having started, changed or stopped her tobacco consumption (for smokers consuming more than 10 cigarettes per day) in the previous 6 months 18.Having taken a medicinal treatment which could lead to hyper pigmentation (phenytoïn, amiodarone, metals, minocycline…) in the previous 6 months 19.Taking oral supplements with major or minor effect on whitening of skin (e.g. vitamin C, beta-carotene…) 20.Having had beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask …) or having applied self-tanning products in the week preceding the start of the study 21.Having applied products with anti-wrinkle action (Retinoic acid, retinol, retinaldehyde, isotretinoin, A.H.A...) in the 2 weeks preceding the start of the study 22.Having applied products with a depigmenting action (hydroquinone or derivates…) in the 4 weeks preceding the start of the study. 23.Having undergone physical and/or chemical treatments of the spots (liquid nitrogen, dry ice, pulsed flash lamp, dermabrasion, chemical peel …) in the previous 6 months 24.Having a suntanned skin on the studied areas which could interfere with the evaluations of the study. 25.Refusing to follow the restrictions below during the study:.
  • •Do not start, change or stop a hormonal treatment (hormonal contraception, Hormone Replacement Therapy).
  • •Do not start a medicinal treatment which could lead to hyper pigmentation.
  • •Do not take oral supplements with major or minor effect on whitening of skin (e.g. vitamin C, beta-carotene…).
  • •Do not start an oral or local retinoid-based treatment.
  • •Do not have beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask …) or apply self-tanning products.
  • •Do not use products or techniques or surgery with a depigmenting action.
  • •Do not practice sport the days of study.
  • •Do not expose yourself to the sun by respecting a strict photo-protection.

结局指标

主要结局

To evaluate the in-vivo efficacy and safety of a skin care regime in terms of skin brightening & skin radiance on healthy female subjects.

时间窗: Baseline, day 14 , Day 28

次要结局

未报告次要终点

研究者

发起方
BRIGHT LIFECARE PVT. LTD.
申办方类型
Other [fmcg]

研究点 (1)

Loading locations...

相似试验

尚未招募
不适用
Safety & efficacy assessment of products on skin.
CTRI/2021/11/038345Sun Pharmaceutical Industries Limited
已完成
不适用
Evaluation of safety & Efficacy of skin care formulation
CTRI/2022/05/042747Transformative Learning Solution Pvt Ltd36
已完成
不适用
Clinical Efficacy Evaluation of a Skincare Product for Acne Face, Upper Chest and Back Used by Multiphototype Population Under Dermatological ControlAcne
NCT06786442Cosmetique Active International130
已完成
不适用
Safety & Efficacy assessment of skin care formulatio
CTRI/2022/06/043429Transformative Learning Solution Pvt Ltd34
已完成
不适用
Evaluation of safety & Efficacy of skin care formulatio
CTRI/2022/05/042503Transformative Learning Solution Pvt Ltd33